Back to Search
Start Over
Allergan reports positive 3 month topline results from second phase 3 study of Bimatoprost SR
- Source :
- PharmaBiz. January 9, 2019
- Publication Year :
- 2019
-
Abstract
- Allergan plc, a leading global pharmaceutical company, announced positive 3-month topline results from the second pivotal clinical trial of Bimatoprost SR, a first-in-class sustained-release, biodegradable implant for the reduction of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.568821390